Skip to content

The effect of reducing light bulb distance in reducing jaundice in newborns with jaundic

Efficacy and complication the distance phototherapy lamps of the surface body infant with jaundice

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170922036321N1
Enrollment
60
Registered
2017-12-02
Start date
2017-05-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaundice. Neonatal jaundice, unspecified

Interventions

Intervention 1: The control group was treated with phototherapy at a distance of 45 cm from the body surface of the newborn's body. Intervention 2: Intervention group: This group was treated with phot
Treatment - Other
Treatment - Devices
The control group was treated with phototherapy at a distance of 45 cm from the body surface of the newborn's body.
Intervention group: This group was treated with phototherapy at a distance of 20 cm from the body surface of the newborn's body

Sponsors

Vice chancellor for research, Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Days to 21 Days

Inclusion criteria

Inclusion criteria: Term neonate(gestational age >32 weeks) with weight more than 2000 grams; No congenital anomalies? No congenital infections; Normal suking reflux;neonate after 24 hours had diuresis and defication; Bilirubin serum in the second day (10-15 mg/dl), third day (13-17 mg/dl), fourth day (14-15 mg/dl),fifth to seventh days (15-18 mg/dl) seventh days and more (18-20 mg/dl)l; there is no indication of Rh incompatibility. weight more than 2000 grams No congenital anomalies? No congenital infections Normal suking reflux neonate after 24 hours had diuresis and defication neonate age older than 24 hours Bilirubin serum in the second day (10-15 mg/dl), third day (13-17 mg/dl), fourth day (14-15 mg/dl),fifth to seventh days (15-18 mg/dl) seventh days and more (18-20 mg/dl) there is no indication of Rh incompatibility

Exclusion criteria

Exclusion criteria: Parental withdrawal from continuing research with infants infected during the study Patient's need for blood transfusion Patient's need for IVIG jaundice due to the following causes; G6PD deficiency and hypothyroidism; and Rh and ABO incompatibility; and evidence of hemolysis

Design outcomes

Primary

MeasureTime frame
Neonatal blood serum Bilirubin. Timepoint: At the reception, 12 hours and 24 hours after the start of phototherapy. Method of measurement: Neonatal venous blood sampling.

Secondary

MeasureTime frame
Baby body temperature. Timepoint: Every 6 hours. Method of measurement: thermometer.;Skin rash. Timepoint: Every 8 hours. Method of measurement: Abservation.;Weight Loss. Timepoint: Daily. Method of measurement: Daily weighing.;Incidence of loose stools. Timepoint: Every 8 hours. Method of measurement: Abservation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Parvin

Mrs Roghayeh Zardosht

parvinf1@mums.ac.ir+98 51 4401 1300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026